These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6671125)

  • 1. Low-dose-rate extrapolation using the multistage model.
    Portier C; Hoel D
    Biometrics; 1983 Dec; 39(4):897-906. PubMed ID: 6671125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating additional biological phenomena into two-stage cancer models.
    Sielken RL; Bretzlaff RS; Stevenson DE
    Prog Clin Biol Res; 1994; 387():237-60. PubMed ID: 7972250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal design of the chronic animal bioassay.
    Portier C; Hoel D
    J Toxicol Environ Health; 1983 Jul; 12(1):1-19. PubMed ID: 6631999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose.
    Gaylor DW; Swirsky Gold L
    Regul Toxicol Pharmacol; 1998 Dec; 28(3):222-5. PubMed ID: 10049793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint propagation of variability and imprecision in assessing the risk of groundwater contamination.
    Baudrit C; Guyonnet D; Dubois D
    J Contam Hydrol; 2007 Aug; 93(1-4):72-84. PubMed ID: 17321003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear interpolation algorithm for low dose risk assessment of toxic substances.
    Gaylor DW; Kodell RL
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):305-12. PubMed ID: 7217854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cancer slope factors using different statistical approaches.
    Subramaniam RP; White P; Cogliano VJ
    Risk Anal; 2006 Jun; 26(3):825-30. PubMed ID: 16834636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confidence intervals and test of hypotheses concerning dose response relations inferred from animal carcinogenicity data.
    Crump KS; Guess HA; Deal KL
    Biometrics; 1977 Sep; 33(3):437-51. PubMed ID: 911968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of inter-individual heterogeneity into the multistage carcinogenesis model: approach to the analysis of cancer incidence data.
    Izumi S; Ohtaki M
    Biom J; 2007 Aug; 49(4):539-50. PubMed ID: 17722193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model averaging using fractional polynomials to estimate a safe level of exposure.
    Faes C; Aerts M; Geys H; Molenberghs G
    Risk Anal; 2007 Feb; 27(1):111-23. PubMed ID: 17362404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extinction risk of a meta-population: aggregation approach.
    Hakoyama H; Iwasa Y
    J Theor Biol; 2005 Jan; 232(2):203-16. PubMed ID: 15530490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling motor vehicle crashes using Poisson-gamma models: examining the effects of low sample mean values and small sample size on the estimation of the fixed dispersion parameter.
    Lord D
    Accid Anal Prev; 2006 Jul; 38(4):751-66. PubMed ID: 16545328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A generalized multihit dose-response model for low-dose extrapolation.
    Rai K; Van Ryzin J
    Biometrics; 1981 Jun; 37(2):341-52. PubMed ID: 7272419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do low dose-rate bystander effects influence domestic radon risks?
    Brenner DJ; Sachs RK
    Int J Radiat Biol; 2002 Jul; 78(7):593-604. PubMed ID: 12079538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symmetry, identifiability, and prediction uncertainties in multistage clonal expansion (MSCE) models of carcinogenesis.
    Cox LA; Huber WA
    Risk Anal; 2007 Dec; 27(6):1441-53. PubMed ID: 18093045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-response model incorporating nonlinear kinetics.
    Van Ryzin J; Rai K
    Biometrics; 1987 Mar; 43(1):95-105. PubMed ID: 3567309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the predictive quality of dose-response after model selection.
    Hu C; Dong Y
    Stat Med; 2007 Jul; 26(16):3114-39. PubMed ID: 17206594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
    Hasegawa R; Koizumi M; Hirose A
    Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.